Anti-Glomerular Basement Membrane Disease

计划入组 300 人 · 首次发布于 2025 年 6 月 12 日

Immunoadsorption in Anti-GBM Glomerulonephritis.

计划入组 8 人 · 首次发布于 2016 年 5 月 9 日

Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?

计划入组 100 人 · 首次发布于 2018 年 9 月 11 日

membrane-active bakuchiol

Membrane stabliser (FORMA Therapeutics)

membrane sealant co-polymer

London Metropolitan University

United Kingdom

MiMedx

United States

Comstock Metals Ltd

Australia

Hansa Biopharma's Phase 3 Trial for Anti-GBM Disease Fails Primary Endpoint Despite Improved Dialysis-Free Outcomes

Hansa Biopharma's Imlifidase Shows Promise in Guillain-Barré Syndrome and Anti-GBM Disease

Hansa Biopharma Secures $24.3M Funding as IDEFIRIX Sales Surge 76% in Q2 2025